The t(4;22)(q12;q11) in atypical chronic myeloid leukaemia fuses BCR to PDGFRA

Human Molecular Genetics

Volumn 11, Issue 12, 2002, Pages

  Baxter, E Joanna ^a   Hochhaus, Andreas ^a   Bolufer, Pascual ^a   Reiter, Andreas ^a   Fernandez, José M ^a   Senent, Leonor ^a   Cervera, José ^a   Moscardo, Federico ^a   Sanz, Miguel A ^a   Cross, Nicholas C P ^a  

^a SALISBURY DISTRICT HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; BCR ABL PROTEIN; BREAKPOINT CLUSTER REGION PROTEIN; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; HYBRID PROTEIN; HYDROXYUREA; MESSENGER RNA; METHOTREXATE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; VINCRISTINE;

ADULT; ARTICLE; BLAST CELL CRISIS; CASE REPORT; CHROMOSOME 22Q; CHROMOSOME 4Q; CHROMOSOME 9Q; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 4; CHROMOSOME TRANSLOCATION 9; CHRONIC MYELOID LEUKEMIA; COMORBIDITY; CONTROLLED STUDY; CYTOGENETICS; EXON; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE REARRANGEMENT; HUMAN; INTRON; LEUKOCYTOSIS; MALE; MOLECULAR CLONING; MYELOPROLIFERATIVE DISORDER; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

ADULT; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 4; FUSION PROTEINS, BCR-ABL; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MALE; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; RNA, MESSENGER; SEQUENCE ANALYSIS, RNA; TRANSLOCATION, GENETIC;

EID: 70350186921     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Chronic myeloproliferative diseases
2. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype
3. Cytogenetics of chronic myeloid leukaemia
4. The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways
5. ZNF198-FGFR1 transforms Ba/F3 cells to growth factor independence and results in high level tyrosine phosphorylation of STATS 1 and 5
6. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Ab1 positive cells
7. CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins
8. The novel activation of ABL by fusion to an ets-related gene, TEL
9. A novel BCR-JAK2 fusion gene is the result of a translocation t(9;22)(p24;q11) in a case of CML
10. The t(8;22) in atypical chronic myeloid leukemia fuses BCR to FGFR1: Transforming activity and specific inhibition of FGFR1 fusion proteins
11. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: The first fusion gene involving BCR but not ABL
12. Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor α receptor expression in human malignant gliomas
13. Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease
14. Induction of platelet-derived growth factor receptor A and B chains and over-expression of their receptors in human pancreatic cancer
15. An optimised multiplex polymerase chain reaction for detection of BCR-ABL fusion mRNAs in haematological disorders
16. Fusion of a novel gene, BTL, to ETV6 in acute myeloid leukaemias with a t(4;12)(q11-q12; p13)
17. FISH study of variant Philadelphia rearrangements
18. Cytogenetic peculiarities in chronic myelogenous leukemia
19. Karyotypic evolution in a granulocytic sarcoma developing in a myeloproliferative disorder with a novel (3;4) translocation
20. Chronic myeloid leukemia associated hypereosinophilic syndrome with a clonal t(4;7)(q11;q32)
21. Complete haematological and cytogenetic response to interferon alpha-2a of a myeloproliferative disorder with eosinophilia associated with a unique t(4;7) aberration
22. A coiled-coil oligomerisation domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins
23. Myeloproliferative disorders with translocations of 5q31-q35: Role of the platelet-derived growth factor beta
24. A single amino acid substitution in a WW-like domain of diverse members of the PDGF receptor subfamily of tyrosine kinases causes constitutive receptor activation
25. Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class
26. Chronic myeloproliferative diseases involving rearrangements of the platelet derived growth factor beta receptor (PDGFRB) showing rapid responses to the tyrosine kinase inhibitor STI571